Document Detail

Structure based design of 11β-HSD1 inhibitors.
MedLine Citation:
PMID:  20809895     Owner:  NLM     Status:  In-Process    
Controlling elevated tissue-specific levels of cortisol may provide a novel therapeutic approach for treating metabolic syndrome. This concept has spurred large scale medicinal chemistry efforts in the pharmaceutical industry for the design of 11β-HSD1 inhibitors. High resolution X-ray crystal structures of inhibitors in complex with the enzyme have facilitated the structure-based design of diverse classes of molecules. A summary of binding modes, trends in structure-activity relationships, and the pharmacodynamic data of inhibitors from each class is presented.
Suresh Singh; Colin Tice
Related Documents :
19403925 - Use of a real-time fluorescence monitoring system for high-throughput screening for pro...
15446845 - Influenza virus neuraminidase inhibitors: generation and comparison of structure-based ...
20035615 - High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a ligh...
11913725 - Site-specific molecular design and its relevance to pharmacogenomics and chemical biology.
23042075 - Identification of potent vhz phosphatase inhibitors with structure-based virtual screen...
24046025 - A novel clade of unique eukaryotic ribonucleotide reductase r2 subunits is exclusive to...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current pharmaceutical biotechnology     Volume:  11     ISSN:  1873-4316     ISO Abbreviation:  Curr Pharm Biotechnol     Publication Date:  2010 Nov 
Date Detail:
Created Date:  2010-11-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100960530     Medline TA:  Curr Pharm Biotechnol     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  779-91     Citation Subset:  IM    
Vitae Pharmaceuticals, 502 W. Office Center Drive, Fort Washington, PA 19034, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Application of NMR spectroscopy in medicinal chemistry and drug discovery.
Next Document:  Open access high throughput drug discovery in the public domain: a Mount Everest in the making.